Published in Gene Therapy Weekly, July 26th, 1999
P.S. Ajmani and colleagues from the University of Florida investigated cationic lipid formulations as non-viral vectors ("3 Beta [N-(N',N'-Dimethylaminoethane)-Carbamoyl] Cholesterol (DC-Chol)-Mediated Gene Delivery to Primary Rat Neurons: Characterization and Mechanism," Neurochemical Research, May 1999;24(5):699-703).
"Cationic lipid formulations consisting of 3 beta [N-(N',N'-dimethylaminoethane)-carbamoyl] cholesterol (DC-Chol) and the helper lipid dioleoylphosphatidylethanolamine (DOPE) (1.5:1 molar ratio) were prepared by solvent evaporation and sized by high pressure...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.